Godsey & Gibb Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Sell
1,185
-5
-0.4% -$5.11K 0.12% 55
2026
Q1
$1.09M Sell
1,190
-7
-0.6% -$7.1K 0.1% 56
2025
Q4
$1.29M Buy
1,197
+90
+8% +$86.1K 0.12% 54
2025
Q3
$845K Buy
1,107
+7
+0.6% +$5.21K 0.07% 60
2025
Q2
$857K Hold
1,100
0.08% 57
2025
Q1
$909K Hold
1,100
0.09% 58
2024
Q4
$849K Sell
1,100
-92
-8% -$76.2K 0.08% 59
2024
Q3
$1.06M Hold
1,192
0.1% 56
2024
Q2
$1.08M Sell
1,192
-15
-1% -$12K 0.11% 58
2024
Q1
$939K Hold
1,207
0.1% 55
2023
Q4
$704K Hold
1,207
0.08% 59
2023
Q3
$648K Sell
1,207
-15
-1% -$7.73K 0.08% 60
2023
Q2
$573K Sell
1,222
-53
-4% -$22.2K 0.07% 63
2023
Q1
$438K Sell
1,275
-100
-7% -$33.7K 0.05% 70
2022
Q4
$503K Buy
+1,375
New +$488K 0.1% 45
2022
Q1
Sell
-1,275
Closed -$352K 124
2021
Q4
$352K Hold
1,275
0.11% 24
2021
Q3
$295K Buy
+1,275
New +$315K 0.13% 21
2021
Q2
Sell
-1,375
Closed -$257K 132
2021
Q1
$257K Sell
1,375
-251
-15% -$49.1K 0.03% 87
2020
Q4
$275K Sell
1,626
-295
-15% -$44K 0.04% 79
2020
Q3
$284K Sell
1,921
-5
-0.3% -$774 0.04% 72
2020
Q2
$316K Buy
1,926
+5
+0.3% +$767 0.05% 72
2020
Q1
$266K Sell
1,921
-25
-1% -$3.44K 0.05% 71
2019
Q4
$256K Hold
1,946
0.04% 83
2019
Q3
$218K Buy
+1,946
New +$217K 0.03% 82

Other funds holding LLY

Godsey & Gibb Inc's LLY Position: Q2 2026 in Review

Godsey & Gibb Inc reduced its Eli Lilly (LLY) stake by 0.42% in Q2 2026, selling an estimated $5.11K and leaving 1,185 shares worth $1.42M. The position accounts for 0.12% of the portfolio, ranked #55.

Godsey & Gibb Inc first reported a position in LLY in Q3 2019 and has held it in 24 quarters since. 1,791 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Godsey & Gibb Inc held 1,185 shares of Eli Lilly worth $1.42M as of Q2 2026.
  • Godsey & Gibb Inc sold 5 Eli Lilly shares in Q2 2026, an estimated $5.11K.
  • Eli Lilly made up 0.12% of Godsey & Gibb Inc's portfolio in Q2 2026, its #55 holding.
  • Godsey & Gibb Inc first reported a position in Eli Lilly in Q3 2019 and has held it in 24 quarters since.
  • 1,791 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.